David J Dabbs Selected Research

David J Dabbs Research Topics

Disease

56	Breast Neoplasms (Breast Cancer) 08/2023 - 02/2002
44	Neoplasms (Cancer) 01/2023 - 02/2002
16	Carcinoma (Carcinomatosis) 01/2022 - 02/2002
10	Lobular Carcinoma 01/2022 - 01/2007
7	Pathologic Complete Response 01/2023 - 01/2009
5	Ductal Carcinoma 01/2022 - 09/2007
5	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2015 - 03/2006
3	Adenocarcinoma 02/2013 - 02/2002
2	Papillary Carcinoma 11/2009 - 02/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Wilms Tumor (Wilm's Tumor) 01/2017
1	Melanoma (Melanoma, Malignant) 07/2014
1	Confusion (Bewilderment) 07/2013
1	Sweat Gland Neoplasms 08/2011
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 06/2010
1	Necrosis 02/2010
1	Papilloma (Papillomatosis) 02/2009
1	Neoplasm Micrometastasis 02/2009
1	Endometrial Neoplasms (Endometrial Cancer) 07/2008
1	Giant Cell Arteritis (Horton Disease) 07/2007
1	Ovarian Cysts (Ovarian Cyst) 07/2007
1	Lymphatic Metastasis 01/2007
1	Hyperplasia 03/2006
1	Neoplasm Metastasis (Metastasis) 03/2004
1	Adenocarcinoma of Lung 02/2002

Drug/Important Bio-Agent (IBA)

28	Estrogen ReceptorsIBA 01/2023 - 02/2002
21	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 02/2002
11	Hormones (Hormone)IBA 01/2021 - 07/2008
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2007
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2008
7	Cadherins (E-Cadherin)IBA 07/2013 - 01/2007
6	Keratins (Keratin)IBA 01/2022 - 03/2004
6	Estrogens (Estrogen)FDA Link 03/2014 - 01/2007
6	Phenobarbital (Luminal)FDA Link 05/2011 - 01/2008
5	AntibodiesIBA 03/2015 - 01/2007
4	human ERBB2 proteinIBA 01/2021 - 05/2011
4	Androgen Receptors (Androgen Receptor)IBA 01/2017 - 02/2010
4	CateninsIBA 07/2013 - 01/2007
3	VimentinIBA 01/2017 - 11/2006
3	Trastuzumab (Herceptin)FDA Link 10/2013 - 02/2010
2	ParaffinIBA 01/2019 - 03/2006
2	ErbB Receptors (EGF Receptor)IBA 07/2012 - 03/2010
2	Formaldehyde (Formol)FDA Link 05/2012 - 03/2006
2	2,4,5-trimethoxyphenylisopropylamine (TMA-2)IBA 11/2009 - 11/2008
2	Monoclonal AntibodiesIBA 03/2007 - 02/2002
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2022
1	Hematoxylin (Haematoxylon)IBA 10/2022
1	somatotropin releasing hormone receptorIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	formic acid (formate)IBA 01/2019
1	Thyroid Nuclear Factor 1IBA 01/2017
1	Uroplakin IIIBA 01/2017
1	Keratin-20 (Cytokeratin 20)IBA 01/2017
1	Keratin-7 (Cytokeratin 7)IBA 01/2017
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 11/2016
1	Tamoxifen FDA LinkGeneric 03/2014
1	DNA ProbesIBA 01/2014
1	Carcinoembryonic AntigenIBA 02/2013
1	Insulin-Like PeptidesIBA 05/2011
1	LigandsIBA 05/2011
1	Somatomedin Receptors (Somatomedin Receptor)IBA 05/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2011
1	Calbindin 2IBA 07/2010
1	SteroidsIBA 07/2010
1	Inhibins (Inhibin)IBA 07/2010
1	MART-1 AntigenIBA 07/2010
1	MucinsIBA 06/2010
1	Green Fluorescent ProteinsIBA 06/2010
1	Progesterone FDA LinkGeneric 02/2010
1	AndrogensIBA 02/2010
1	Transcription Factors (Transcription Factor)IBA 11/2009
1	erucylphosphocholineIBA 02/2009
1	Collagen Type IV (Type IV Collagen)IBA 02/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2008
1	UteroglobinIBA 07/2008
1	Oncogene Proteins (Oncogene Protein)IBA 04/2008
1	Delta CateninIBA 03/2007
1	beta CateninIBA 01/2007
1	alpha Catenin (alpha E-Catenin)IBA 01/2007
1	gamma Catenin (Plakoglobin)IBA 01/2007
1	Combined Antibody TherapeuticsIBA 01/2007
1	Endothelin-1 (Endothelin 1)IBA 10/2006
1	Coloring Agents (Dyes)IBA 03/2004
1	EpitopesIBA 02/2002

Therapy/Procedure

14	Neoadjuvant Therapy 08/2023 - 01/2009
14	Therapeutics 01/2021 - 12/2008
7	Drug Therapy (Chemotherapy) 10/2018 - 02/2010
2	Segmental Mastectomy (Lumpectomy) 07/2014 - 10/2013
1	Radiotherapy 07/2014
1	Mastectomy (Mammectomy) 03/2013
1	Quantum Dots (Quantum Dot) 03/2013
1	Curettage 02/2013
1	Complementary Therapies (Alternative Medicine) 02/2010
1	Aftercare (After-Treatment) 12/2008
1	Salpingo-oophorectomy 07/2007
1	Lymph Node Excision (Lymph Node Dissection) 10/2004